SMARCB1 Loss in Poorly Differentiated Chordomas Drives Tumor Progression.

Tara A Walhart, Bryanna Vacca, Austin J Hepperla, Samera H Hamad, James Petrongelli, Yemin Wang, Erin L McKean, Michelle Moksa, Qi Cao, Stephen Yip, Martin Hirst, Bernard E Weissman

The American journal of pathology 2023 Apr

filter terms:

Poorly differentiated (PD) chordoma, a rare, aggressive tumor originating from notochordal tissue, shows loss of SMARCB1 expression, a core component of the Switch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complexes. To determine the impact of SMARCB1 re-expression on cell growth and gene expression, two SMARCB1-negative PD chordoma cell lines with an inducible SMARCB1 expression system were generated. After 72 hours of induction of SMARCB1, both SMARCB1-negative PD chordoma cell lines continued to proliferate. This result contrasted with those observed with SMARCB1-negative rhabdoid cell lines in which SMARCB1 re-expression caused the rapid inhibition of growth. We found that the lack of growth inhibition may arise from the loss of CDKN2A (p16INK4A) expression in PD chordoma cell lines. RNA-sequencing of cell lines after SMARCB1 re-expression showed a down-regulation for rRNA and RNA processing as well as metabolic processing and increased expression of genes involved in cell adhesion, cell migration, and development. Taken together, these data establish that SMARCB1 re-expression in PD chordomas alters the repertoire of SWI/SNF complexes, perhaps restoring those associated with cellular differentiation. These novel findings support a model in which SMARCB1 inactivation blocks the conversion of growth-promoting SWI/SNF complexes to differentiation-inducing ones, and they implicate SMARCB1 loss as a late event in tumorigenic progression. Importantly, the absence of growth inhibition after SMARCB1 restoration creates a unique opportunity to identify therapeutic vulnerabilities. Copyright © 2023 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Citation

Tara A Walhart, Bryanna Vacca, Austin J Hepperla, Samera H Hamad, James Petrongelli, Yemin Wang, Erin L McKean, Michelle Moksa, Qi Cao, Stephen Yip, Martin Hirst, Bernard E Weissman. SMARCB1 Loss in Poorly Differentiated Chordomas Drives Tumor Progression. The American journal of pathology. 2023 Apr;193(4):456-473